TherapeuticsMD Inc. Stock Falls Monday, Underperforms Market

 

TherapeuticsMD Inc. Stock Falls Monday, Underperforms Market

4/4/22 5:25 PM ET (MarketWatch)Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) slumped 0.69% to $0.37 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.90% to 14,532.55 and the Dow Jones Industrial Average rising 0.30% to 34,921.88. This was the stock's fourth consecutive day of losses. TherapeuticsMD Inc. closed $1.10 below its 52-week high ($1.47), which the company achieved on April 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.97% to $176.47, Merck & Co. Inc. (MRK) fell 0.04% to $83.49, and Novartis AG ADR (NOVN.EB) fell 0.41% to $87.33. Trading volume (2.5 M) remained 4.7 million below its 50-day average volume of 7.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 4, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

April 04, 2022 17:25 ET (21:25 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.